Rothblatt Martine A

Chairperson & CEO, DirectorUNITED THERAPEUTICS Corp (UTHR) · full profile →Form 4 · filed Sep 1, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$4.9M
Net Open-Market Flow
-$4.9M
Transactions
10
9 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Aug 31, 2026Option exercise(M)10K$135.42$1.3M334K
Aug 31, 2026Sell(S)599$507.84$304K333K
Aug 31, 2026Sell(S)794$508.92$404K333K
Aug 31, 2026Sell(S)810$509.84$413K332K
Aug 31, 2026Sell(S)4K$510.93$2.2M328K
Aug 31, 2026Sell(S)2K$511.75$819K326K
Aug 31, 2026Sell(S)678$513.50$348K325K
Aug 31, 2026Sell(S)762$514.32$392K324K
Aug 31, 2026Sell(S)40$514.96$21K324K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Aug 31, 2026Option exercise(M)10K$028K

Transaction Codes

M
Option exercise / conversion
S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001106578-26-000132) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

Build

Build on these Form 4 transactions

The public view is the crawlable proof. The same sourced dataset is available through REST and MCP for agents, research scripts, and back-office tools.